T14	Exp 153 157	that
T15	Exp 366 368	It
T16	Exp 394 397	how
T17	Exp 468 471	why
T18	Exp 421 433	the function
T19	Exp 437 464	the inflammatory infiltrate
T20	Exp 472 483	the disease
T21	Exp 624 629	which
T22	Exp 630 644	the mechanisms
T23	Exp 876 909	the reduced tissue concentrations
T24	Exp 951 976	the diminished expression
T25	Exp 1162 1183	the IkappaBalpha gene
T26	Exp 1200 1225	the nuclear translocation
T27	Exp 1241 1268	the xenotransplanted tissue
T28	Exp 1117 1131	These findings
T29	Exp 1306 1310	that
T30	Exp 1431 1455	the inflammatory lesions
T31	Exp 1501 1511	the T cell
T32	Exp 1549 1563	the activation
T33	Exp 1727 1742	The persistence
T34	Exp 1851 1865	the chronicity
T35	Exp 1869 1880	the disease
T36	Exp 1929 1959	this inflammatory vasculopathy
R4	Coref Anaphora:T14 Antecedent:T37
R5	Coref Anaphora:T15 Antecedent:T38
R6	Coref Anaphora:T21 Antecedent:T39
T1	Protein 913 917	IL-2
T2	Protein 919 927	IL-1beta
T3	Protein 933 937	IL-6
T4	Protein 1029 1038	IFN-gamma
T5	Protein 1091 1100	TGF-beta1
T6	Protein 1166 1178	IkappaBalpha
T7	Protein 1521 1525	IL-2
T8	Protein 1530 1539	IFN-gamma
T9	Protein 1628 1636	IL-1beta
T10	Protein 1679 1688	TGF-beta1
T11	Protein 1746 1755	TGF-beta1
T37	Exp 131 152	a vasculitic syndrome
T38	Exp 214 236	Glucocorticoid therapy
T39	Exp 613 620	a model
